FDA Approved: DOBUTAMINE IN DEXTROSE — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Dobutamine in Dextrose from Hospira, Inc., adding a new formulation to the product’s approved NDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock
• Heart Failure

Drugs mentioned

• DOBUTAMINE IN DEXTROSE (Dobutamine)

Snippet

SUPPL AP for DOBUTAMINE IN DEXTROSE (DOBUTAMINE IN DEXTROSE)